93 results
8-K
EX-10.2
RGBP
Regen BioPharma, Inc.
13 Sep 24
Entry into a Material Definitive Agreement
2:12pm
hereunder. If such funding shall be insufficient for such full satisfaction, then, nevertheless, the Company shall tender in full an amount equivalent … ), or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Conversion Shares which
8-K
EX-10.1
RGBP
Regen BioPharma, Inc.
13 Sep 24
Entry into a Material Definitive Agreement
2:12pm
1 business day following the date hereof, subject to notification of satisfaction of the conditions to the Closing set forth herein and in Sections 7 … to the satisfaction (or waiver) of the terms and conditions of this Agreement, the Investor agrees to purchase at the Closing and the Company agrees to sell
424B3
RGBP
Regen BioPharma, Inc.
10 May 24
Prospectus supplement
3:50pm
or practices, financial statement disclosures, or auditing scope or procedure, which disagreements, if not resolved to BF Borger’s satisfaction, would
8-K
RGBP
Regen BioPharma, Inc.
10 May 24
Changes in Registrant's Certifying Accountant
3:49pm
, or auditing scope or procedure, which disagreements, if not resolved to BF Borger's satisfaction, would have caused BF Borger to make reference to the subject
424B3
sy0jvk9n6jy4u3fu
24 Apr 24
Prospectus supplement
1:28pm
424B3
kh44eqm8t5cbu9e9vbt
19 Jan 24
Prospectus supplement
1:29pm
424B3
ua5e0ueap
20 Nov 23
Prospectus supplement
9:38am
424B3
pqom0o8b
2 Oct 23
Prospectus supplement
1:42pm
8-K
EX-10.2
zyd7xdqjepcuqt20
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm
8-K
EX-10.1
w7yy4kx7322gqb6
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm
8-K
EX-10.3
il8kk3l2lh 7at2o
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm
424B3
j9szstu56zr4wk9a
15 May 23
Prospectus supplement
10:25am